PHOSPHOTEC DIN 02342014
Health Canada record
| Active ingredient(s) | TETRASODIUM PYROPHOSPHATE 40 MG |
|---|---|
| Dosage form | Powder |
| Route | Intravenous; Intravascular |
| Schedule | SCHEDULE C |
| Class | Radiopharmaceutical |
| ATC | |
| Original market date | |
| Current status date | 07-Sep-2022 |
| Source | Health Canada DPD |
Establishment licence of the holder
Bracco Imaging Canada — licence 100427, currently licensed, last inspection rating C (2022-08-30).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing TETRASODIUM PYROPHOSPHATE
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02486016 | STANNOUS PYP KIT | CALGARY RADIOPHARMACEUTICAL CENTRE / ALBERTA HEALTH SERVICES | Solution; Kit | TETRASODIUM PYROPHOSPHATE 20 MG | Marketed |
| 02513870 | KIT FOR THE PREPARATION OF TECHNETIUM (99MTC) PYROPHOSPHATE INJECTION | ISOLOGIC INNOVATIVE RADIOPHARMACEUTICALS LTD. | Powder For Solution | TETRASODIUM PYROPHOSPHATE 12 MG | Dormant |
| 02345889 | STANNOUS PYROPHOSPHATE | EDMONTON RADIOPHARMACEUTICAL CENTRE (ALBERTA HEALTH SERVICES) | Powder For Solution | TETRASODIUM PYROPHOSPHATE 11.9 MG; STANNOUS CHLORIDE 3.4 MG | Cancelled Pre Market |
| 02329301 | TECHNESCAN PYP | MALLINCKRODT CANADA ULC | Powder For Solution | TETRASODIUM PYROPHOSPHATE 11.9 MG; STANNOUS CHLORIDE 4.4 MG | Cancelled Pre Market |